NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bivision Pharma

Private
NanjingHealthcare & Life Sciences

Last Round

Series A

Jul 26, 2024

Total Funding Raised

$28.6M

Company Overview

Bivision Pharma is a drug discovery, life sciences, and pharmaceuticals and biotechnology company that develops innovative therapies for ophthalmic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

targeted radionuclide therapyTRTradiopharmaceuticalsradiopharmaradioligand therapytheranosticsmetastatic castration-resistant prostate cancermCRPCprostate cancer therapyPSMA targeted therapyLutetium-177Lu-177oncology drug developmentclinical-stage biopharmasolid tumor therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bivision Pharma Comps

Public and private peers based on sector, stage, and business model.

Bivision Pharma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bivision Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 26, 2024
VC RoundMay 14, 2024
AngelMay 1, 2022

Bivision Pharma Investors

Notable investors and investment history

Bivision Pharma investors
InvestorRounds
华金大道投资有限公司Series A
Kaitai CapitalAngel
Huajin CapitalSeries A
Gaorong CapitalSeries A, Angel, VC Round
Hongli Innovation InvestmentAngel, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2024

    $14M round led by Huajin Capital and 华金大道投资有限公司

  • May 14, 2024

    Led by Gaorong Capital and Hongli Innovation Investment.

Bivision Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bivision Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bivision Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Year Founded2021
Last FundingJul 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.